These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 40664)

  • 1. Rebound effect after stopping beta-blockers.
    Lewis MJ; Ross PJ; Henderson AH
    Br Med J; 1979 Sep; 2(6190):606. PubMed ID: 40664
    [No Abstract]   [Full Text] [Related]  

  • 2. Adrenergic hypersensitivity after beta-blocker withdrawal.
    Ross PJ; Lewis MJ; Sheridan DJ; Henderson AH
    Br Heart J; 1981 Jun; 45(6):637-42. PubMed ID: 6114739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blocker withdrawal syndrome.
    Dollery CT; Maling TJ
    Br Med J; 1979 Oct; 2(6197):1074-5. PubMed ID: 229940
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rebound reaction after beta-adrenergic blockers].
    Belanová M; Inczinger F
    Cesk Fysiol; 1983; 32(6):535-45. PubMed ID: 6141009
    [No Abstract]   [Full Text] [Related]  

  • 5. The beta-adrenergic blockade withdrawal phenomenon.
    Walden RJ; Tomlinson B; Bhattacharjee P; Prichard BN
    J Pharmacol; 1983; 14 Suppl 2():35-48. PubMed ID: 6138470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol withdrawal changes cardiovascular responses to propranolol challenge.
    Kähkönen S
    Neuropsychobiology; 2003; 47(4):192-7. PubMed ID: 12824742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The syndrome associated with the withdrawal of beta-adrenergic receptor blocking drugs.
    Prichard BN; Walden RJ
    Br J Clin Pharmacol; 1982; 13(Suppl 2):337S-343S. PubMed ID: 6125186
    [No Abstract]   [Full Text] [Related]  

  • 8. [Withdrawal of preparations blocking beta-adrenergic receptors].
    Prichard BN; Bhattacharjee P; Tomlinson B; Walden RJ
    Ter Arkh; 1982; 54(11):38-45. PubMed ID: 6130620
    [No Abstract]   [Full Text] [Related]  

  • 9. [Symptoms and cardiovascular complications of the withdrawal of beta-blocker treatment. Practical implications].
    Plouin PF
    Therapie; 1984; 39(4):379-90. PubMed ID: 6148791
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of beta-adrenergic receptor blocking drugs in psychiatry.
    Whitlock FA; Price J
    Drugs; 1974; 8(2):109-24. PubMed ID: 4154835
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanism-based modeling of rebound tachycardia after chronic l-propranolol infusion in spontaneous hypertensive rats.
    Brynne L; Paalzow LK; Karlsson MO
    J Pharmacol Exp Ther; 1999 Aug; 290(2):664-71. PubMed ID: 10411576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration.
    Aarons RD; Nies AS; Gal J; Hegstrand LR; Molinoff PB
    J Clin Invest; 1980 May; 65(5):949-57. PubMed ID: 6102572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular drug withdrawal syndromes. A potential problem with calcium antagonists?
    Raftery EB
    Drugs; 1984 Nov; 28(5):371-4. PubMed ID: 6150842
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of propranolol on cognitive flexibility and memory in acute cocaine withdrawal.
    Kelley BJ; Yeager KR; Pepper TH; Bornstein RA; Beversdorf DQ
    Neurocase; 2007 Oct; 13(5):320-7. PubMed ID: 18781429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha- and beta-receptor blocking drugs in the treatment of hypertension.
    Ram CV; Kaplan NM
    Curr Probl Cardiol; 1979 Jan; 3(10):1-53. PubMed ID: 40755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Withdrawal effects following interruption of antihypertensive drugs. II. Coronary rebound phenomenon with antihypertensive drugs used in coronary heart disease therapy (author's transl)].
    Laham E
    Sem Hop; 1979 Dec 8-15; 55(41-42):1905-8. PubMed ID: 231311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Propranolol protects the myocardium and prevents arterial hypotension in an experimental organ donation model].
    Ojeda Rivero R; Cerro Sánchez J; Ordóñez Fernández A; Domínguez Roldán JM; Hernández Fernández A
    Rev Esp Anestesiol Reanim; 2002 May; 49(5):229-37. PubMed ID: 12216505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sympathetic-adrenal system in ischemic heart disease before and after obzidan treatment].
    Orlov VN; Chigrinova LS
    Klin Med (Mosk); 1981 Jun; 59(6):74-8. PubMed ID: 6116820
    [No Abstract]   [Full Text] [Related]  

  • 19. [Role of the adrenergic system in atherogenesis and effects of beta-blockers].
    Pauletto P; Dal Palù C
    G Ital Cardiol; 1989 Jun; 19(6):507-22. PubMed ID: 2572503
    [No Abstract]   [Full Text] [Related]  

  • 20. Stopping beta blockers in patients with angina.
    Rangno RE
    Ration Drug Ther; 1981 Sep; 15(9):1-4. PubMed ID: 6127751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.